Cargando…
Novel biomarker SYT12 may contribute to predicting papillary thyroid cancer outcomes
AIM: To investigate biomarkers for predicting papillary thyroid cancer outcomes. MATERIALS & METHODS: The expression of biomarkers (ITGA2, SYT12 and CDH3) was studied in a prospective cohort of patients with papillary thyroid cancer. Three outcomes of initial metastases, baseline status and long...
Autores principales: | Jonklaas, J, Murthy, SRK, Liu, D, Klubo-Gwiezdzinska, J, Krishnan, J, Burman, KD, Boyle, L, Carrol, N, Felger, E, Loh, Y P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729603/ https://www.ncbi.nlm.nih.gov/pubmed/29255621 http://dx.doi.org/10.4155/fsoa-2017-0087 |
Ejemplares similares
-
Efficacy of Dosimetric Versus Empiric Prescribed Activity of (131)I for Therapy of Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011) -
Syt-12 for spontaneous release
por: LeBrasseur, Nicole
Publicado: (2007) -
SAT556 An Unusual Case of Papillary Thyroid Carcinoma With Biallelic MEN1 Variants In a Patient With MEN1
por: Chuki, Elias, et al.
Publicado: (2023) -
SYT12 is a novel oncogene that promotes thyroid carcinoma progression and metastasis
por: Jin, Lingli, et al.
Publicado: (2021) -
THYROID EMERGENCIES
por: Ylli, Dorina, et al.
Publicado: (2019)